FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

10722811000001107: Solpadeine Plus tablets (GlaxoSmithKline Consumer Healthcare) 16 tablet 2 x 8 tablets (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Apr 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
36934601000001119 Solpadeine Plus tablets (GlaxoSmithKline Consumer Healthcare) 16 tablet 2 x 8 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
72644101000001117 Solpadeine Plus tablets (Omega Pharma Ltd) 16 tablet 2 x 8 tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Solpadeine Plus tablets (GlaxoSmithKline Consumer Healthcare) 16 tablet 2 x 8 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 5 (CD Inv) true Inferred relationship Existential restriction modifier
Solpadeine Plus tablets (GlaxoSmithKline Consumer Healthcare) 16 tablet 2 x 8 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Solpadeine Plus tablets (GlaxoSmithKline Consumer Healthcare) 16 tablet 2 x 8 tablets Is a Generic Solpadeine Plus tablets 16 tablet true Inferred relationship Existential restriction modifier
Solpadeine Plus tablets (GlaxoSmithKline Consumer Healthcare) 16 tablet 2 x 8 tablets Is pack of Solpadeine Plus tablets (GlaxoSmithKline Consumer Healthcare) false Inferred relationship Existential restriction modifier
Solpadeine Plus tablets (GlaxoSmithKline Consumer Healthcare) 16 tablet 2 x 8 tablets Has active ingredient Codeine phosphate false Inferred relationship Existential restriction modifier
Solpadeine Plus tablets (GlaxoSmithKline Consumer Healthcare) 16 tablet 2 x 8 tablets Has active ingredient Caffeine false Inferred relationship Existential restriction modifier
Solpadeine Plus tablets (GlaxoSmithKline Consumer Healthcare) 16 tablet 2 x 8 tablets Has active ingredient Paracetamol false Inferred relationship Existential restriction modifier
Solpadeine Plus tablets (GlaxoSmithKline Consumer Healthcare) 16 tablet 2 x 8 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Solpadeine Plus tablets (GlaxoSmithKline Consumer Healthcare) 16 tablet 2 x 8 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Solpadeine Plus tablets (GlaxoSmithKline Consumer Healthcare) 16 tablet 2 x 8 tablets Legal category Pharmacy medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Solpadeine Plus tablets (GlaxoSmithKline Consumer Healthcare) 16 tablet 2 x 8 tablets VMP prescribing status (attribute) Never valid to prescribe as a VMP true Inferred relationship Existential restriction modifier
Solpadeine Plus tablets (GlaxoSmithKline Consumer Healthcare) 16 tablet 2 x 8 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Solpadeine Plus tablets (GlaxoSmithKline Consumer Healthcare) 16 tablet 2 x 8 tablets Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Solpadeine Plus tablets (GlaxoSmithKline Consumer Healthcare) 16 tablet 2 x 8 tablets Has AMP Solpadeine Plus tablets (GlaxoSmithKline Consumer Healthcare) true Inferred relationship Existential restriction modifier
Solpadeine Plus tablets (GlaxoSmithKline Consumer Healthcare) 16 tablet 2 x 8 tablets Has specific active ingredient Codeine phosphate true Inferred relationship Existential restriction modifier
Solpadeine Plus tablets (GlaxoSmithKline Consumer Healthcare) 16 tablet 2 x 8 tablets Has specific active ingredient Caffeine true Inferred relationship Existential restriction modifier
Solpadeine Plus tablets (GlaxoSmithKline Consumer Healthcare) 16 tablet 2 x 8 tablets Has specific active ingredient Paracetamol true Inferred relationship Existential restriction modifier
Solpadeine Plus tablets (GlaxoSmithKline Consumer Healthcare) 16 tablet 2 x 8 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Solpadeine Plus tablets (GlaxoSmithKline Consumer Healthcare) 16 tablet 2 x 8 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Solpadeine Plus tablets (GlaxoSmithKline Consumer Healthcare) 16 tablet 2 x 8 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start